Clinical Trial Update: Intravitreal Bevacizumab for Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

The update describes intravitreal bevacizumab being studied for diabetic macular edema in Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Isfahan Ophthalmology Research Center | Conditions: Macular Edema, Diabetic Retinopathy | Phase 2, Phase 3 | Status: UNKNOWN